Marsh & McLennan Underperforming Dow Jones Industrial Average: Key Insights and Analysis.
ByAinvest
Wednesday, Sep 3, 2025 6:22 am ET1min read
MMC--
The company's performance has remained grim over the longer term as well. MMC stock has dropped 3.3% year-to-date (YTD) and 9.7% over the past 52 weeks, lagging behind the Dow's 6.5% gains in 2025 and a 9% surge over the past year. The stock has consistently been below its 50-day and 200-day moving averages since early April and June, respectively [1].
Despite delivering better-than-expected results, MMC's stock prices observed a marginal 44 bps dip in the trading session following the release of its Q2 results on July 17. The company's overall revenues for the quarter surged 12.1% year-over-year to $6.97 billion, surpassing the Street expectations by 75 bps. Additionally, the company's adjusted EPS for the quarter increased by an impressive 11.5% year-over-year to $2.72, exceeding the consensus estimates by 2.3%. Following the initial dip, MMC stock prices gained 59 bps in the subsequent trading session [1].
Among the 22 analysts covering the MMC stock, the overall consensus rating is a "Hold." Its mean price target of $234.58 suggests a 14.2% upside potential from current price levels. However, MMC has notably underperformed its peer, Arthur J. Gallagher & Co.'s (AJG) 6.6% gains on a YTD basis and 3.4% uptick over the past 52 weeks [1].
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
References:
[1] https://www.shawneefeed.com/news/story/34557550/is-marsh-mclennan-stock-underperforming-the-dow
Marsh & McLennan Companies (MMC) provides advice and solutions to clients worldwide in the areas of risk, strategy, and people. Despite notable strengths, MMC stock has plunged 17.2% from its all-time high and has underperformed the Dow Jones Industrial Average by 12.5% over the past three months. MMC's performance has remained grim over the longer term as well, with a 3.3% YTD loss and a 9.7% decline over the past 52 weeks. The stock has consistently been below its 50-day and 200-day moving averages since early April and June, respectively.
Marsh & McLennan Companies (MMC) has seen its stock price plunge significantly over the past several months, despite delivering strong financial results. The New York-based company, which provides advice and solutions in the areas of risk, strategy, and people, has experienced a 17.2% drop from its all-time high of $248, touched on April 4. Over the past three months, MMC's stock has underperformed the Dow Jones Industrial Average by 12.5%, with the index gaining 7.1% during the same period [1].The company's performance has remained grim over the longer term as well. MMC stock has dropped 3.3% year-to-date (YTD) and 9.7% over the past 52 weeks, lagging behind the Dow's 6.5% gains in 2025 and a 9% surge over the past year. The stock has consistently been below its 50-day and 200-day moving averages since early April and June, respectively [1].
Despite delivering better-than-expected results, MMC's stock prices observed a marginal 44 bps dip in the trading session following the release of its Q2 results on July 17. The company's overall revenues for the quarter surged 12.1% year-over-year to $6.97 billion, surpassing the Street expectations by 75 bps. Additionally, the company's adjusted EPS for the quarter increased by an impressive 11.5% year-over-year to $2.72, exceeding the consensus estimates by 2.3%. Following the initial dip, MMC stock prices gained 59 bps in the subsequent trading session [1].
Among the 22 analysts covering the MMC stock, the overall consensus rating is a "Hold." Its mean price target of $234.58 suggests a 14.2% upside potential from current price levels. However, MMC has notably underperformed its peer, Arthur J. Gallagher & Co.'s (AJG) 6.6% gains on a YTD basis and 3.4% uptick over the past 52 weeks [1].
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
References:
[1] https://www.shawneefeed.com/news/story/34557550/is-marsh-mclennan-stock-underperforming-the-dow

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet